Zeptri Indications/Uses

Susceptible strains: Staphylococcus aureus (including penicillinase-producing strains), Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes (Group A β-hemolysis), Streptococcus agalactiae (Group B), Streptococcus viridans, Streptococcus bovis, Aeromonas spp., Alcaligenes spp., Moraxella catarrhalis, Citrobacter spp., Enterobacter spp. (some strains are resistant), Escherichia coli, Haemophilus ducreyi, Haemophilus influenzae (including Ampicillin resistant strains). Haemophilus parainfluenzae, Klebsiella spp. (K. pneumoniae), Moraxella spp., Moraxella morganii, Proteus mirabilis, Proteus vulgaris, Providencia spp., Neisseria gonorrhoeae (including penicillinase-producing strains), Neisseria meningitidis, Plesiomonas shigelloides, Pseudomonas aeruginosa (some strains are resistant), Salmonella spp. (including S. typhi), Serratia spp. (including S. marcescens), Shigella spp., Yersinia spp. (including Y. enterocolitica), Treponema pallidum, Bacteroides spp. (including some strains of B. fragilis), Clostridium spp. (except C. difficile), Fusobacterium (except F. mortiferum and F. varium), Peptococcus, Peptostreptococcus.
Indications: Respiratory tract infections such as pneumonia, bronchitis, etc.; Ear, nose and throat infections; Renal and urinary tract infections, genital infection such as gonorrhea; Sepsis; Perioperative prophylaxis of infections; Infections of bones and joints; Infections of skin, wounds and soft tissue; Peritonitis, cholecystitis, cholangitis and infections of gastrointestinal tract; Infections in patients with immunodeficiency; Meningitis.